Skip to main content
Sequana Medical N.V. logo

Sequana Medical N.V. — Investor Relations & Filings

Ticker · SEQUA ISIN · BE0974340722 LEI · 8755009AN12Y4PEOII07 BR Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2026-01-06 Major Shareholding Noti…
Country BE Belgium
Listing BR SEQUA

About Sequana Medical N.V.

https://www.sequanamedical.com/

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Recent filings

Filing Released Lang Actions
Press Release -- Transparency Notification BlackRock (NL) (6 January 2026).pdf
Major Shareholding Notification Classification · 100% confidence The document is a 'Transparantiekennisgeving van Aandeelhouders' (Transparency Notification of Shareholders) issued by Sequana Medical NV. It details a change in shareholding levels (specifically BlackRock and Kreos Capital crossing the 3% threshold). This type of regulatory disclosure regarding significant share ownership is classified as a Major Shareholding Notification.
2026-01-06 Dutch
PR Kreos Amendment (ENG) (23 December 2025).pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a non-binding letter of intent to amend the terms of an existing loan (the 'Kreos Loan'). It details specific changes to the loan structure, such as extending the interest-only period and deferring amortization payments. This falls directly under the definition of 'Capital/Financing Update' (CAP), as it concerns the company's financing activities and capital structure adjustments.
2025-12-23 English
PR Kreos Amendment (NL) (23 december 2025).pdf
Capital/Financing Update Classification · 95% confidence The document is a press release from Sequana Medical announcing a non-binding letter of intent to modify the terms of an existing loan agreement with Kreos Capital. This involves changes to interest payment periods and the deferral of principal repayments. This falls under the category of company financing and capital structure updates. It is not a full report, but a specific announcement regarding debt financing terms.
2025-12-23 Dutch
6th GEM Capital Increase -- Closing PR (ENG) (22 December 2025).pdf
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Sequana Medical NV announcing an increase in share capital and the number of outstanding shares following a subscription request under a share subscription facility agreement. It details the issuance of new shares, the impact on share capital, and provides a comprehensive list of outstanding subscription rights and warrants. This falls under the category of share issuance and capital changes, which is specifically defined as 'SHA'.
2025-12-22 English
6th GEM Capital Increase -- Closing PR (NL) (22 December 2025).pdf
Share Issue/Capital Change Classification · 100% confidence The document is a press release from Sequana Medical NV announcing a change in share capital and the number of outstanding shares following a subscription by GEM Global Yield LLC SCS. It details the issuance of new shares, the status of outstanding subscription rights (warrants/options), and references regulatory requirements (Article 15 of the Belgian Law of 2 May 2007). This is a formal announcement of a capital change and share issuance, which falls under the 'Share Issue/Capital Change' category.
2025-12-22 Dutch
Sequana Medical -- Press Release (ENG) (17 December 2025).pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal 'Transparency Notification' issued by Sequana Medical NV. It details changes in major shareholding positions (BlackRock and SFPIM) and explicitly references the Belgian Act of 2 May 2007 regarding the disclosure of major participations. This type of filing is specifically designed to notify the market when a shareholder crosses a significant ownership threshold (e.g., 3% or 5%). According to the provided definitions, this falls under 'Major Shareholding Notification'.
2025-12-17 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.